Named Patient Program Services
Patient-specific access to medicines unavailable in India.
When a treating physician identifies a medicine that is not commercially available in India, the next step is to assess whether it can be accessed for that patient. MitoGENE NPP™ supports patients, families and physicians with sourcing, documentation and import coordination under the applicable pathway.
From the initial enquiry to delivery planning, we provide one point of coordination while the treating physician remains responsible for treatment decisions.
Prescription-led. Patient-specific. Subject to applicable permissions.
Coordinated with care
Support through each stage of access
Who we support
Patients and caregivers seeking access to a prescribed medicine; treating physicians assessing a patient-specific requirement; and hospital teams coordinating documentation and delivery.
Case and Documentation Review
We review the requested medicine, prescription, required quantity and supporting documents to identify the information needed for an access assessment.
International Sourcing
We source suitable options, product details, availability and supplier documentation for the prescribed medicine.
Import and Customs Coordination
We help coordinate the applicable patient-specific documentation, import permit and customs requirements; for eligible personal-use imports, this may involve a Form 12B application and a Form 13B permit issued by CDSCO.
Temperature-Controlled Transport
Where required, we coordinate product-specific packaging, transport and handling arrangements with logistics providers.
Delivery and Continuation Planning
We coordinate delivery arrangements and help assess future supply requirements against the physician’s prescription and applicable permissions.
A clear way forward
How It Works
Start with a prescription-led enquiry. We help you understand what is needed before any access arrangements proceed.
Share the requirement
Tell us which medicine has been prescribed and how we can contact you.
Complete the assessment
We clarify the case details and request the documents needed to assess a possible pathway.
Review the arrangements
Review available sourcing options, estimated costs, documentation and proposed logistics.
Coordinate the next steps
If eligible and agreed, we support the applicable permissions and delivery planning.
An enquiry is not a confirmation of supply. Access depends on availability, prescription, eligibility and applicable permissions.
Documentation & Preparation
What to have ready
For the detailed assessment, our team may request the physician’s prescription, a brief treatment summary, relevant diagnostic reports, patient identification and authorisation, and the intended delivery details. The exact documents depend on the medicine and access route.
FAQs
Frequently asked questions
Yes. A patient or caregiver may make the initial enquiry. Clinical suitability and the prescription must come from the treating physician.
No. An approval granted overseas does not by itself permit import into India. Import is subject to Indian regulatory requirements, and we can help you understand the pathway that applies.
Timelines depend on the medicine, the documentation and the regulatory steps involved. We share an indicative timeline once we have reviewed your enquiry.
Where permitted, yes. We can help plan repeat supply for continuing treatment, subject to the treating physician’s prescription and applicable approvals.
No. MitoGENE does not recommend medicines or treatment. All clinical decisions rest with the treating physician.
Start with the prescribed requirement
Share the medicine details and your contact information. Our team will explain the next steps for a patient-specific assessment.
Request Medicine Access
Disclaimer: MitoGENE facilitates patient-specific access under applicable Indian requirements and physician supervision. This page does not promote unapproved medicines or provide medical advice. Access is subject to eligibility, permissions and supply availability.